The ReoPro Retavase Reperfusion of Stroke Safety Study (ROSIE) is an NIH-sponsored Phase II trial evaluating intravenous reteplase in combination with abciximab for the treatment of patients with ...

Intravenous thrombolysis is a standard treatment of acute ischemic stroke. The efficacy and safety of combining intravenous thrombolysis with argatroban (an anticoagulant agent) or eptifibatide ...

The first NeuroThera Effectiveness and Safety Trial (NEST-1) was initiated to explore the safety and preliminary effectiveness of a new laser technique for the treatment of ischemic stroke.

The Microplasmin in Treatment of Ischemic Stroke – Intravenous (MITI-IV) trial, evaluated the safety and efficacy of intravenous microplasmin in 40 patients. There was no evidence of increased ...

Hemorrhagic stroke makes up about one-third of all stroke cases. Here, we break down: What a hemorrhagic stroke is  What's ...

ACTEAST aims to improve access and efficiency of treatment for ischemic stroke across all 4 provinces in Atlantic Canada. Stroke is a devastating disease, as it is the leading cause of severe physical ...

The incidence of stroke continues to increase for adults and children living with sickle cell disease (SCD), despite the ...

Figure 1: Graphical depiction of the variation between patients in evolution of ischemic brain injury ... collateral flow and guide treatment strategies in acute stroke. Maas et al.

A new study indicates the incidence of stroke continues to increase for adults and children living with sickle cell disease ...

At a thrombosis research center, an observational study is underway investigating the impact of numerous biomarkers on ...

Genesis Health System received the American Heart Association’s Get With The Guidelines Stroke Silver Plus quality achievement award for its commitment to ensuring stroke patients receive the most app ...